Mallinckrodt completes rolling submission of biologics license for stratagraft regenerative skin tissue to fda

Mallinckrodt completes rolling submission of biologics license application for stratagraft® regenerative skin tissue to u.s. food and drug administration.mallinckrodt plc - stratagraft skin tissue is in development as potential new treatment option for patients with deep partial-thickness thermal burns.mallinckrodt plc - stratagraft skin tissue is an investigational product, and its safety and effectiveness have not yet been established by fda..
MNK Ratings Summary
MNK Quant Ranking